Navigation Links
DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
Date:5/3/2012

CUPERTINO, Calif., May 3, 2012 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced the issuance of four patents by the United States Patent and Trademark Office (USPTO) covering DURECT's ORADUR technology.  These patents provide additional intellectual property protection for REMOXY (oxycodone) Extended-Release Capsules CII and other ORADUR-based opioids until at least 2025. REMOXY, based on DURECT's ORADUR technology, is an investigational drug that is a unique, controlled release formulation of oxycodone for moderate-to-severe chronic pain designed to reduce potential risks of unintended use.

"The four new patents expand on the intellectual property coverage afforded REMOXY and other ORADUR-based opioids, and the issuance of these patents indicates that the USPTO recognizes the unique aspects of our controlled release, tamper-resistant technology," stated James Brown, President and CEO of DURECT. 

The four recently issued patents are U.S. Patent Nos. 8,133,507; 8,147,870; 8,153,152; and 8,168,217.  The '507, '152, and '217 patents claim oral formulations comprising an opioid, such as oxycodone, and other components.  The '870 patent claims methods of making opioid-containing formulations.  Several more patent applications covering REMOXY and other ORADUR-based opioids are pending, including patent applications which, if granted, would result in patents expiring in 2028, plus any eligible patent term adjustments and extensions.  In Europe, REMOXY and other ORADUR-based product candidates are covered by two granted patents expiring in 2016 and 2023, respectively, plus any eligible patent term extensions.

About REMOXY®

REMOXY, based on DURECT's ORADUR® technology, is an investigational drug that is a unique, controlled release formulation of oxycodone for moderate-to-severe chronic pain designed
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DURECT Corporation Invites You to Join Its Fourth Quarter 2011 Earnings Conference Call
2. DURECT to Participate in Upcoming Healthcare Conferences
3. DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)
4. DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call
5. DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST)
6. DURECT Corporation to Participate in Upcoming Healthcare Conferences
7. DURECT Corporation Announces Second Quarter 2011 Financial Results and Update of Programs
8. DURECT Corporation Invites You to Join its Second Quarter 2011 Earnings Conference Call
9. DURECT to Present at the Jefferies Healthcare Conference
10. DURECT Announces Resignation of Chief Medical Officer
11. DURECT to Present at the UBS Global Specialty Pharmaceuticals Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Juli 2015 BioClinica®, Inc ., ... Studien, gab heute bekannt, dass es mit MediciGroup ... Gewinnung und Erhalt von Patienten übernommen hat. ... , Ltd. und Access to Patients, LLC. Medici ... zum Auffinden von Patienten, die für die Nachbeobachtung ...
(Date:7/7/2015)... The Global Breast Pumps Market is ... an estimated CAGR of 7.6% from 2014 to 2020, according ... of innovative technologies including hand free breast pumps, growing women ... advantages of breast milk are expected to drive breast pump ... untapped growth opportunities in emerging markets such as ...
(Date:7/7/2015)...   Bionik Laboratories Corp. (OTCBB: BNKL), ... core focus in robotic exoskeleton technology for users ... today that it has completed an additional sale ... its common stock and warrants for aggregate gross ... placement transaction.  This equity financing is the sixth ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... 2011  Merrimack Pharmaceuticals, Inc. announced today that the ... 1 clinical study combining MM-121, a fully human ... and irinotecan (Camptosar®) in patients with advanced cancers. ... The Phase 1 study evaluates the safety ...
... Addressing concerns over anti-mail-service pharmacy legislation, New York ... the legislature have agreed to amend NY AB 5502-B, ... use of the lower cost mail-service pharmacy option. ... admonition to the Legislature to improve this costly, anti-consumer ...
Cached Medicine Technology:Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers 2PCMA: Governor Cuomo's Call to Amend Anti-Mail-Service Pharmacy Law Protects Employers and Consumers 2PCMA: Governor Cuomo's Call to Amend Anti-Mail-Service Pharmacy Law Protects Employers and Consumers 3
(Date:7/7/2015)... , ... July 07, 2015 , ... Silverado today issues ... ground as early as Summer 2015 on a four-acre site in Bellingham, Washington. Cordata ... the support of city officials and other members of the local community. , The ...
(Date:7/7/2015)... and CHICAGO (PRWEB) , ... July 07, 2015 ... ... healthcare business development and growth strategy expert Jay Warden as Senior Vice President, ... for the company’s efforts to provide the best solutions to healthcare providers’ needs ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... cancer screenings at the Aspen Ideas Festival (AIF), identifying 18 possible melanomas and ... diagnoses must be confirmed with additional testing. , The Aspen Ideas Festival, which ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... MRI services, is debuting their brand new website. The website’s goal is to ... a wider selection of patient tools, including requesting appointments online. , Part of ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... The United ... AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition $3.78 ... other men who have sex with men (MSM) and transgender women, the groups ...
Breaking Medicine News(10 mins):Health News:New Silverado Memory Care Community Receives Unanimous Approval from Design Review Board 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3
... the important risk factor for psychoactive drugs abuse//. ... like marijuana, stimulants, opiates, cocaine and psychedelics was ... genetic makeup – researchers report. ,In ... Virginia Commonwealth University researchers, in collaboration with researchers ...
... All India Institute of Medical Sciences remained crippled today ... protest the move to sack its Director P Venugopal//. ... closed since last evening as resident doctors and faculty ... body headed by Union Health Minister A Ramadoss recommended ...
... A succinct report has laid unbelievable blunders on the table ... slip-ups or have just escaped by the skin of their ... falsifying figures.NHS is simply unable to fathom the losses for ... could be close to a million ,The slip ...
... to a recent research it was found that teenagers who ... other hard drugs// later in their life. ,Teenagers ... to the positive emotion that they derive by taking these ... which further leads a person to get exposed to other ...
... issue", consuming 30c for every $1 spent on health, according ... in its report on this year's estimates for Vote Health,called ... and indicated exhausted doctors and nurses as one factor. ... who suffered an unintended or negative event while in care. ...
... discovered a safe and effective way to sanitize seeds used ... colleagues at the University of Guelph, have developed a sanitizer ... the same chemicals used in toothpaste and contact lens solutions. ... by a magic bullet is that it can selectively kill ...
Cached Medicine News:Health News:Genetic Factors linked with Drug Dependence and Abuse 2Health News:Sanitizer For Contaminated Sprouts Developed 2
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Lyphochek Assayed Chemistry Control requires no special diluent and has good reconstituted stability for enzymes and CO2. It is assayed for most major instruments and methodologies....
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Medicine Products: